Acute severe ulcerative colitis (ASUC) is associated with a significant risk of colectomy and requires timely and effective medical intervention to reduce morbidity and mortality. However, designing ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM research study has found. To perform the study, scientists from the ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC) shows that, contrary to concerns, ...

Ulcerative colitis (UC) is a lifelong condition. That means you may try a lot of different treatments — and know how frustrating it can be when they don’t help. The nature of UC is “flare and ...

Older adults hospitalized with acute severe ulcerative colitis (ASUC) face substantially higher mortality rates, and current guidelines do not provide specific recommendations for this population. In ...

The goal of ulcerative colitis (UC) treatment is to ease your symptoms and keep you in that state as long as possible. For most people, this means taking one or more medications. There are many ...

Share on Pinterest Ulcerative colitis treatment drug Omvoh, from Eli Lilly, was linked to sustained clinical remission after 4 years, according to new trial data. Image credit: Plexi ...

You’ve followed your ulcerative colitis (UC) treatment plan to a T, and yet you’re still experiencing symptoms that won’t let up — or even seem to be taking a turn for the worse. There’s an ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases, particularly acute myocardial infarction, are the leading cause of disability and ...